We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$104B
AUM Growth
+$9.45B
Cap. Flow
+$9.9B
Cap. Flow %
9.52%
Top 10 Hldgs %
28.08%
Holding
8,130
New
449
Increased
3,536
Reduced
3,324
Closed
388

Sector Composition

Rank Sector Weight
1 Healthcare 5.43%
2 Energy 4.72%
3 Technology 4.42%
4 Financials 3.4%
5 Consumer Discretionary 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FORR icon
6526
Forrester Research
FORR
$224M
$14K ﹤0.01%
375
+162
+76% +$6.2K
MRTN icon
6527
Marten Transport
MRTN
$1.19B
$14K ﹤0.01%
2,080
+917
+79% +$7.44K
NUWE icon
6528
Nuwellis
NUWE
$550K
0
OSUR icon
6529
OraSure Technologies
OSUR
$270M
$14K ﹤0.01%
1,957
-55,158
-97% -$441K
PKOH icon
6530
Park-Ohio Holdings
PKOH
$682M
$14K ﹤0.01%
301
-141
-32% -$8.09K
RARE icon
6531
Ultragenyx Pharmaceutical
RARE
$2.67B
$14K ﹤0.01%
244
+125
+105% +$6.29K
ROCK icon
6532
Gibraltar Industries
ROCK
$1.47B
$14K ﹤0.01%
1,078
-1,536
-59% -$23.5K
STAA icon
6533
STAAR Surgical
STAA
$1.25B
$14K ﹤0.01%
1,315
+571
+77% +$6.79K
SUP
6534
DELISTED
Superior Industries International
SUP
$14K ﹤0.01%
824
-3,197
-80% -$62.3K
TGTX icon
6535
TG Therapeutics
TGTX
$7.68B
$14K ﹤0.01%
1,472
+1,067
+263% +$9.89K
TRC icon
6536
Tejon Ranch
TRC
$453M
$14K ﹤0.01%
491
+244
+99% +$6.86K
TXMD icon
6537
TherapeuticsMD
TXMD
$24.1M
$14K ﹤0.01%
71
+37
+109% +$9.32K
XRAY icon
6538
CALL
Dentsply Sirona
XRAY
$2.32B
$14K ﹤0.01%
300
-500
-63% -$23.5K
CPAY icon
6539
PUT
Corpay
CPAY
$26.8B
$14K ﹤0.01%
+100
New +$13.8K
CBAY
6540
DELISTED
Cymabay Therapeutics
CBAY
$14K ﹤0.01%
+2,400
New +$14.7K
BKCC
6541
DELISTED
BlackRock Capital Investment Corporation
BKCC
$14K ﹤0.01%
1,801
-21,561
-92% -$195K
SFE
6542
DELISTED
Safeguard Scientifics, Inc.
SFE
$14K ﹤0.01%
723
-337
-32% -$6.65K
KSPN
6543
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$14K ﹤0.01%
239
-213
-47% -$15.5K
SMM
6544
DELISTED
Salient Midstream & MLP Fund
SMM
$14K ﹤0.01%
475
FOE
6545
PUT
DELISTED
Ferro Corporation
FOE
$14K ﹤0.01%
1,000
PCOM
6546
DELISTED
Points.com Inc. Common Shares
PCOM
$14K ﹤0.01%
+836
New +$16.3K
TTPH
6547
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$14K ﹤0.01%
37
+17
+85% +$4.55K
CGI
6548
DELISTED
Celadon Group Inc
CGI
$14K ﹤0.01%
736
-736
-50% -$15.6K
CASC
6549
DELISTED
Cascadian Therapeutics, Inc.
CASC
$14K ﹤0.01%
2,363
+229
+11% +$3.5K
BOXC
6550
DELISTED
Brookfield Can Office Properties
BOXC
$14K ﹤0.01%
600

Similar funds

Barclays's Q3 2014 Portfolio in Review

As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.

  • Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
  • Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
  • Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
  • Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
  • Barclays opened 449 new positions and closed 388 in Q3 2014.
  • Barclays's portfolio value rose 10% quarter-over-quarter to $104B.

Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.